Literature DB >> 20407038

Human NLRP3 inflammasome activation is Nox1-4 independent.

Robin van Bruggen1, M Yavuz Köker, Machiel Jansen, Michel van Houdt, Dirk Roos, Taco W Kuijpers, Timo K van den Berg.   

Abstract

The NLRP3 inflammasome can be activated by pathogen-associated molecular patterns or endogenous danger-associated molecular patterns. The activation of the NLRP3 inflammasome results in proteolytic activation and secretion of cytokines of the interleukin-1 (IL-1) family. The precise mode of activation of the NLRP3 inflammasome is still elusive, but has been postulated to be mediated by reactive oxygen species (ROS) generated by an NADPH oxidase. Using primary cells from chronic granulomatous disease (CGD) patients lacking expression of p22(phox), a protein that is required for the function of Nox1-4, we show that cells lacking NADPH oxidase activity are capable of secreting normal amounts of IL-1beta. Thus, we provide evidence that activation of the NLRP3 inflammasome does not depend on ROS generated from an NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407038     DOI: 10.1182/blood-2009-10-250803

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  86 in total

1.  Inflammasomes in cardiovascular diseases.

Authors:  Nisha Jain Garg
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 2.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

Review 3.  Pathogen control at the intestinal mucosa - H2O2 to the rescue.

Authors:  Ulla G Knaus; Rosanne Hertzberger; Gratiela G Pircalabioru; S Parsa M Yousefi; Filipe Branco Dos Santos
Journal:  Gut Microbes       Date:  2017-01-12

Review 4.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 5.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

6.  Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.

Authors:  Shankar S Iyer; Qiong He; John R Janczy; Suzanne L Cassel; Fayyaz S Sutterwala; Eric I Elliott; Zhenyu Zhong; Alicia K Olivier; Jeffrey J Sadler; Vickie Knepper-Adrian; Renzhi Han; Liang Qiao; Stephanie C Eisenbarth; William M Nauseef
Journal:  Immunity       Date:  2013-08-15       Impact factor: 31.745

Review 7.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

Review 8.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

9.  Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.

Authors:  José Pablo Vázquez-Medina; Jian-Quin Tao; Priyal Patel; Renata Bannitz-Fernandes; Chandra Dodia; Elena M Sorokina; Sheldon I Feinstein; Shampa Chatterjee; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

Review 10.  Control of innate and adaptive immunity by the inflammasome.

Authors:  Ceren Ciraci; John R Janczy; Fayyaz S Sutterwala; Suzanne L Cassel
Journal:  Microbes Infect       Date:  2012-07-24       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.